A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Abstract The novel coronavirus disease (COVID-19) pandemic remains a global public health crisis, presenting a broad range of challenges. To help address some of the main problems, the scientific community has designed vaccines, diagnostic tools and therapeutics for severe acute respiratory syndrome...
Main Authors: | Monika Kumari, Ruei-Min Lu, Mu-Chun Li, Jhih-Liang Huang, Fu-Fei Hsu, Shih-Han Ko, Feng-Yi Ke, Shih-Chieh Su, Kang-Hao Liang, Joyce Pei-Yi Yuan, Hsiao-Ling Chiang, Cheng-Pu Sun, I.-Jung Lee, Wen-Shan Li, Hsing-Pang Hsieh, Mi-Hua Tao, Han-Chung Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-022-00852-9 |
Similar Items
-
Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
by: Ruei-Min Lu, et al.
Published: (2023-05-01) -
A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo
by: Jana Van Dycke, et al.
Published: (2021-09-01) -
Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses
by: Tyler J. Ogorek, et al.
Published: (2023-02-01) -
Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1
by: Ilina Bhattacharya, et al.
Published: (2022-04-01) -
Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Michelle Felicia Lee, et al.
Published: (2023-03-01)